MedPath

Royal Victoria Infirmary

🇬🇧United Kingdom
Ownership
-
Established
1751-01-01
Employees
-
Market Cap
-
Website
http://www.newcastle-hospitals.org.uk/hospitals/royal-victoria-infirmary.aspx

Clinical Trials

4

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 1
1 (33.3%)

Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients

Not Applicable
Conditions
Idiopathic Pulmonary Fibrosis
Cough
Breathlessness
First Posted Date
2012-11-30
Last Posted Date
2012-12-12
Lead Sponsor
Royal Victoria Infirmary
Target Recruit Count
30
Registration Number
NCT01738711
Locations
🇬🇧

Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Completed
Conditions
Moderate to Severe Atopic Eczema
First Posted Date
2012-04-03
Last Posted Date
2012-04-05
Lead Sponsor
Royal Victoria Infirmary
Target Recruit Count
58
Registration Number
NCT01569906
Locations
🇬🇧

Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom

News

UK Performs First EASEE Brain Implant Surgery for Drug-Resistant Epilepsy at Newcastle Hospitals

Newcastle Hospitals successfully completed the UK's first implantation of the EASEE device, a pioneering brain stimulation implant developed by German company Precisis for treating focal epilepsy.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.